Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in CRMD — CorMedix Inc.

CIK 902219 Boston, MA
Back to CRMD Full portfolio

Position in CRMD

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,693,990
+$307,032 QoQ
Shares Held
215,795
+5.6% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 194 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 0% Shared 69% None 31%

Common Shares in CRMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. CRMD ranks #134 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in CRMD

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,693,990 215,795
2026-03-31 $1,386,958 204,265
2025-12-31 $2,579,067 221,760
2025-09-30 $2,911,778 250,368
2025-06-30 $2,108,173 171,118
2025-03-31 $1,009,925 163,949
2024-12-31 $1,448,166 178,786
2024-09-30 $1,462,059 180,948
2024-06-30 $339,562 78,421